Alvotech

Iceland
Reykjavík, Capital Region, Iceland, 101

Company profile

Alvotech company profile

Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company's goal is to improve patients' health and quality of life around the world by increasing access to effective therapies for various ailments. Alvotech was established on January 1, 2013, by Róbert Wessman in Reykjavík, Gullbringusysla.

Business identity

Contact email
[email protected]
Phone number
+354 422 4500
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$10M-$100M
Founded
2013-01-01

Headquarters

Postal code
101
Country code
IS
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
12
Total equity funding
$398.5M
Last funding
Post IPO Debt / $100M / 2025-12-31
Last equity funding
Post IPO Equity / $33.2M
Investors
7
Lead investors
3
Founders
1
Articles
542
Exited on
2022-06-16

Founders and investors

Founders

Róbert Wessman

Lead investors

AlvogenFuji PharmaGoldenTree Asset Management

Investors

AlvogenAthos CapitalBaxter VenturesGoldenTree Asset ManagementShinhan Capital